tiprankstipranks
Covista (CVSA)
NYSE:CVSA

Covista (CVSA) AI Stock Analysis

365 Followers

Top Page

CVSA

Covista

(NYSE:CVSA)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
$128.00
▲(8.47% Upside)
Action:ReiteratedDate:03/04/26
The score is supported mainly by strong financial performance (high margins and solid free cash flow) and a constructive earnings update (raised EPS guidance and continued operational momentum). Offsetting factors include weaker technical trend signals (below key moving averages and negative MACD) and only moderate valuation support based on the provided P/E.
Positive Factors
High Profitability & Margins
Sustained high gross and operating margins indicate durable pricing power and scalable delivery across programs. These margins support consistent cash generation and provide a buffer against enrollment volatility, enabling reinvestment, margin-driven EPS growth, and stable returns over multiple quarters.
Negative Factors
Top-line Growth Deceleration
A slowdown to ~3% TTM revenue growth from earlier stronger growth curtails the company’s ability to rely on scale to drive future margin and EPS expansion. Continued deceleration raises pressure on management to deliver sustained enrollment recovery or else rely more on margin levers and buybacks to sustain earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability & Margins
Sustained high gross and operating margins indicate durable pricing power and scalable delivery across programs. These margins support consistent cash generation and provide a buffer against enrollment volatility, enabling reinvestment, margin-driven EPS growth, and stable returns over multiple quarters.
Read all positive factors

Covista (CVSA) vs. SPDR S&P 500 ETF (SPY)

Covista Business Overview & Revenue Model

Company Description
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the ...
How the Company Makes Money
Adtalem generates the majority of its revenue from student tuition and related educational fees charged by its universities and professional schools. Key revenue streams include (1) tuition from undergraduate and graduate degree programs (notably ...

Covista Financial Statement Overview

Summary
Strong profitability and margins (TTM gross margin ~58.5%, operating margin ~19.7%, net margin ~13.7%) and robust free cash flow generation (~$368M TTM; ~85% of net income). Balance sheet leverage is manageable and improving (debt-to-equity ~0.53), but debt remains material and revenue growth has decelerated (TTM ~3.0% vs higher prior-year growth).
Income Statement
82
Very Positive
Balance Sheet
74
Positive
Cash Flow
77
Positive
BreakdownTTMJun 2025Jun 2024Jun 2022Jun 2020Jun 2019
Income Statement
Total Revenue1.89B1.79B1.58B1.45B906.90M1.05B
Gross Profit1.08B1.02B886.10M774.10M460.02M567.84M
EBITDA428.91M427.31M346.96M377.42M241.05M265.51M
Net Income253.25M232.68M136.78M96.93M76.91M202.23M
Balance Sheet
Total Assets2.61B2.75B2.74B2.81B3.08B2.23B
Cash, Cash Equivalents and Short-Term Investments56.28M199.60M219.31M272.19M476.38M500.52M
Total Debt729.55M774.00M847.85M896.19M1.30B527.19M
Total Liabilities1.24B1.32B1.37B1.35B1.78B915.41M
Stockholders Equity1.38B1.43B1.37B1.46B1.30B1.31B
Cash Flow
Free Cash Flow368.01M287.57M246.88M165.90M152.32M68.09M
Operating Cash Flow427.89M337.90M295.77M191.91M192.20M107.69M
Investing Cash Flow-57.35M-41.92M-47.85M23.74M-56.69M382.52M
Financing Cash Flow-507.32M-316.02M-301.80M-288.51M676.47M-256.11M

Covista Technical Analysis

Technical Analysis Sentiment
Positive
Last Price118.00
Price Trends
50DMA
105.13
Positive
100DMA
103.89
Positive
200DMA
116.90
Positive
Market Momentum
MACD
3.74
Negative
RSI
67.11
Neutral
STOCH
74.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CVSA, the sentiment is Positive. The current price of 118 is above the 20-day moving average (MA) of 111.23, above the 50-day MA of 105.13, and above the 200-day MA of 116.90, indicating a bullish trend. The MACD of 3.74 indicates Negative momentum. The RSI at 67.11 is Neutral, neither overbought nor oversold. The STOCH value of 74.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CVSA.

Covista Risk Analysis

Covista disclosed 45 risk factors in its most recent earnings report. Covista reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Covista Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
85
Outperform
$2.29B11.8916.30%1.88%24.23%17.56%
75
Outperform
$1.90B14.057.66%2.99%3.74%-8.40%
74
Outperform
$5.05B17.6726.41%2.01%-13.82%
73
Outperform
$4.07B12.3217.76%12.24%52.97%
73
Outperform
$4.66B21.4428.22%7.05%-2.63%
64
Neutral
$4.71B16.286.53%0.65%4.13%228.37%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CVSA
Covista
118.00
11.52
10.82%
PRDO
Perdoceo Education
36.71
10.99
42.72%
LOPE
Grand Canyon Education
171.76
-2.31
-1.33%
STRA
Strategic Education
83.47
4.37
5.52%
GHC
Graham Holdings
1,079.56
151.38
16.31%
LAUR
Laureate Education
35.39
15.83
80.93%

Covista Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Covista Refinances Debt with New Seven-Year Term Loans
Positive
Mar 3, 2026
On March 2, 2026, Covista Inc. amended its existing credit agreement with a syndicate of lenders led by Morgan Stanley Senior Funding, Inc., incurring new term loans totaling $510 million that mature on March 2, 2033, and lowering its term loan in...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 04, 2026